Skip to main content
View expanded cover

CRISPR Gene Editing pp 127–134Cite as

Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs

Part of the Methods in Molecular Biology book series (MIMB,volume 1961)

Abstract

CRISPR/Cas9 is an effective and easy-to-use tool for editing the genome of many human cancer cell lines. However, in some hard-to-transfect cell lines and primary cells, gene editing is more challenging. This protocol details an electroporation-based protocol for the delivery of Cas9 protein from Streptococcus pyogenes complexed with chemically modified sgRNAs. We have found this protocol to work very efficiently in numerous cell lines and primary cells that are difficult to transfect by conventional chemical-based transfection methods.

Key words

  • CRISPR/Cas9
  • Gene editing
  • Chemically modified sgRNAs
  • Electroporation
  • Nucleoporation
  • Gene knockout

This is a preview of subscription content, access via your institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4939-9170-9_9
  • Chapter length: 8 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   169.00
Price excludes VAT (USA)
  • ISBN: 978-1-4939-9170-9
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   219.99
Price excludes VAT (USA)
Learn about institutional subscriptions
Fig. 1
Fig. 2

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Barrangou R, May AP (2015) Unraveling the potential of CRISPR-Cas9 for gene therapy. Expert Opin Biol Ther 15(3):311–314. https://doi.org/10.1517/14712598.2015.994501

    CAS  CrossRef  PubMed  Google Scholar 

  2. Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, Vrbanac V, Garrison BS, Stortchevoi A, Bryder D, Musunuru K, Brand H, Tager AM, Allen TM, Talkowski ME, Rossi DJ, Cowan CA (2014) Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15(5):643–652. https://doi.org/10.1016/j.stem.2014.10.004

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  3. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE (2011) STING is a direct innate immune sensor of cyclic di-GMP. Nature 478(7370):515–518. https://doi.org/10.1038/nature10429

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  4. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G (2002) Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168(9):4531–4537

    CAS  CrossRef  Google Scholar 

  5. Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, Bacchetta R, Tsalenko A, Dellinger D, Bruhn L, Porteus MH (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33(9):985–989. https://doi.org/10.1038/nbt.3290

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  6. Kim S, Kim D, Cho SW, Kim J, Kim JS (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24(6):1012–1019. https://doi.org/10.1101/gr.171322.113

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  7. Yin H, Song CQ, Suresh S, Wu Q, Walsh S, Rhym LH, Mintzer E, Bolukbasi MF, Zhu LJ, Kauffman K, Mou H, Oberholzer A, Ding J, Kwan SY, Bogorad RL, Zatsepin T, Koteliansky V, Wolfe SA, Xue W, Langer R, Anderson DG (2017) Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing. Nat Biotechnol 35(12):1179–1187. https://doi.org/10.1038/nbt.4005

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  8. Lee K, Mackley VA, Rao A, Chong AT, Dewitt MA, Corn JE, Murthy N (2017) Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering. elife 6:e25312. https://doi.org/10.7554/eLife.25312

    CrossRef  PubMed  PubMed Central  Google Scholar 

  9. Wong TK, Neumann E (1982) Electric field mediated gene transfer. Biochem Biophys Res Commun 107(2):584–587

    CAS  CrossRef  Google Scholar 

  10. Chicaybam L, Sodre AL, Curzio BA, Bonamino MH (2013) An efficient low cost method for gene transfer to T lymphocytes. PLoS One 8(3):e60298. https://doi.org/10.1371/journal.pone.0060298

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  11. Bak RO, Porteus MH (2017) CRISPR-mediated integration of large gene cassettes using AAV donor vectors. Cell Rep 20(3):750–756. https://doi.org/10.1016/j.celrep.2017.06.064

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  12. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281–2308. https://doi.org/10.1038/nprot.2013.143

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  13. Brinkman EK, Chen T, Amendola M, van Steensel B (2014) Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res 42(22):e168. https://doi.org/10.1093/nar/gku936

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  14. Bak RO, Dever DP, Porteus MH (2018) CRISPR/Cas9 genome editing in human hematopoietic stem cells. Nat Protoc 13(2):358–376. https://doi.org/10.1038/nprot.2017.143

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

R.O.B. gratefully acknowledges the support from a Lundbeck Foundation Fellowship (R238-2016-3349), an AIAS-COFUND (Marie Curie) fellowship from Aarhus Institute of Advanced Studies (AIAS) co-funded by Aarhus University’s Research Foundation and the European Union’s seventh Framework Program under grant agreement no 609033, the Novo Nordisk Foundation (NNF17OC0028894), Innovation Fund Denmark (8056-00010B), the Carlsberg Foundation (CF17-0129), Slagtermester Max Wørzner og Hustru Inger Wørzners Mindelegat, The AP Møller Foundation, and the Riisfort Foundation.

Author information

Authors and Affiliations

  1. Department of Biomedicine, Aarhus University, Aarhus, Denmark

    Anders Laustsen & Rasmus O. Bak

  2. Aarhus Institute of Advanced Studies (AIAS), Aarhus University, Aarhus, Denmark

    Rasmus O. Bak

Authors
  1. Anders Laustsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rasmus O. Bak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rasmus O. Bak .

Editor information

Editors and Affiliations

  1. Department of Biomedicine, Aarhus University, Aarhus, Denmark

    Yonglun Luo

Rights and permissions

Reprints and Permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Verify currency and authenticity via CrossMark

Cite this protocol

Laustsen, A., Bak, R.O. (2019). Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs. In: Luo, Y. (eds) CRISPR Gene Editing. Methods in Molecular Biology, vol 1961. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9170-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9170-9_9

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-9169-3

  • Online ISBN: 978-1-4939-9170-9

  • eBook Packages: Springer Protocols